Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
Omnicell (DE:OC9)
FRANKFURT:OC9
Omnicell (OC9) Stock Price & Analysis
0 Followers
OC9 Stock Chart & Stats
Day’s Range€0 - €0
52-Week Range€24.00 - €71.00
Previous Close€26
Volume0.00
Average Volume (3M)8.00
Market Cap
€1.17B
Enterprise Value€1.32B
Total Cash (Recent Filing)$446.80M
Total Debt (Recent Filing)$601.69M
Price to Earnings (P/E)N/A
Beta0.25
Next Earnings
May 02, 2024EPS Estimate
-€0.09Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)N/A
Shares Outstanding45,915,296
10 Day Avg. Volume1
30 Day Avg. Volume8
Standard DeviationN/A
R-SquaredN/A
AlphaN/A
Financial Highlights & Ratios
Price to Book (P/B)5.17
Price to Sales (P/S)3.79
Price to Cash Flow (P/CF)8.10
P/FCF Ratio8.10
Enterprise Value/Market CapN/A
Enterprise Value/Revenue1.22
Enterprise Value/Gross Profit2.24
Enterprise Value/Ebitda45.95
Forecast
1Y Price Target
€28.88Price Target Upside11.06% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering7
Omnicell News
PremiumCompany Announcements
Omnicell Announces Executive Retirement and New VP Appointment
Bulls Say, Bears Say
Bulls Say
Financial PerformanceWith the higher Average Selling Price of the XR2 equipment, which could be about twice that of the IVX, significant revenue boosts are anticipated from these sales.
Operational EfficiencyManagement's strategic decision to hire consultants for a business review may unlock additional margins, showing a proactive approach to improving financial health.
Product InnovationOMCL announced XT Amplify, an umbrella term for several XT-cabinet solutions, potentially leading to incremental revenue through innovation in their product offerings.
Bears Say
Company OutlookThe product revenue growth may continue to decline into 2025, based on current backlog mix and bookings guidance.
Financial Performance2024 guidance is below consensus, indicating potential revenue and EBITDA challenges ahead.
Operational EfficiencyData regarding job openings may be overstated by approximately 18% or about 9 positions/robots.
---
Options Prices
Currently, No data available
---
Ownership Overview
0.00% Insiders
0.00% Mutual Funds
2.59% Other Institutional Investors
97.41% Public Companies and
Individual Investors
OC9 FAQ
What was Omnicell’s price range in the past 12 months?
Omnicell lowest stock price was €24.00 and its highest was €71.00 in the past 12 months.
What is Omnicell’s market cap?
Currently, no data Available
When is Omnicell’s upcoming earnings report date?
Omnicell’s upcoming earnings report date is May 02, 2024 which is in 7 days.
How were Omnicell’s earnings last quarter?
Omnicell released its earnings results on Feb 08, 2024. The company reported €0.311 earnings per share for the quarter, beating the consensus estimate of €0.145 by €0.166.
Is Omnicell overvalued?
According to Wall Street analysts Omnicell’s price is currently Undervalued.
Does Omnicell pay dividends?
Omnicell does not currently pay dividends.
What is Omnicell’s EPS estimate?
Omnicell’s EPS estimate is -€0.09.
How many shares outstanding does Omnicell have?
Currently, no data Available
What happened to Omnicell’s price movement after its last earnings report?
Omnicell reported an EPS of €0.311 in its last earnings report, beating expectations of €0.145. Following the earnings report the stock price went down -16%.
Which hedge fund is a major shareholder of Omnicell?
Among the largest hedge funds holding Omnicell’s share is Fisher Asset Management LLC. It holds Omnicell’s shares valued at 9M.
---
Omnicell Stock Smart Score
Neutral
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Moderate Buy
Average Price Target:
€28.88 (11.06% Upside)
€28.88 (11.06% Upside)
Blogger Sentiment
Bullish
DE:OC9 Sentiment 100%
Sector Average 70%
Sector Average 70%
News Sentiment
Neutral
Bullish news 50%
Bearish news 50%
Bearish news 50%
Technicals
SMA
Negative
20 days / 200 days
Momentum
-55.38%
12-Months-Change
Fundamentals
Return on Equity
-1.76%
Trailing 12-Months
Asset Growth
0.73%
Trailing 12-Months
Company Description
Omnicell
Omnicell, Inc. engages in the provision of medication management automation solutions and adherence tools for healthcare systems and pharmacies. Its solutions include intelligence; platform and interoperability; central pharmacy dispensing; medication adherence; population health; and point of care automation. The company was founded by Randall A. Lipps in September 1992 and is headquartered in Mountain View, CA.
---
OC9 Company Deck
---
OC9 Earnings Call
Q4 2024
0:00 / 0:00
---
OC9 Stock 12 Months Forecast
Average Price Target
€28.88
▲(11.06% Upside)
Technical Analysis
Best Analysts Covering OC9
1 Year
1 Year Success Rate
5/14 ratings generated profit
1 Year Average Return
-1.13%
reiterated a buy rating 3 months ago
Copying Bill Sutherland's trades and holding each position for 1 Year would result in 35.71% of your transactions generating a profit, with an average return of -1.13% per trade.
---